The National Institute for Health and Clinical Excellence has issued its first draft guidance under its new medical technologies programme, recommending the drug-coated balloon catheter SeQuent Please for in-stent restenosis.

The device consists of balloon angioplasty and local delivery of the drug paclitaxel to treat the blocked region, and is designed to relieve angina symptoms and reduce the risk of symptom recurrence and restenosis.

Following a cost analysis by the Medical Technologies Advisory Committee the Institute has endorsed the use of B. Braun’s balloon catheter for patients with restenosis, where an artery becomes re-blocked following previous treatment with a bare metal stent.

According to Carole Longson, Director of the NICE Centre for Health Technology Evaluation, the MTAC felt that SeQuent Please “may benefit patients and the NHS in the long term by reducing the number of cases requiring further treatment for restenosis”, after cost models indicated that its use was associated with a saving of £739 per patient compared with standard therapy.